Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Aktuelle Urologie
|
March 28, 2018
[Immunotherapy for renal cell carcinoma - current status]
Marc-Oliver Grimm, Susan Foller
Urologie (Heidelberg, Germany)
|
November 17, 2023
[Combination therapy with poly(adenosine diphosphate-ribose) polymerase (PARPi) and androgen receptor signaling pathway (ARPi) inhibitors for metastatic castration-resistant prostate cancer]
Marc-Oliver Grimm, Susan Foller, Katharina Leucht
Journal of Clinical Medicine
|
November 27, 2021
Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma
Marc-Oliver Grimm, Katharina Leucht, Susan Foller
Cancers
|
September 23, 2022
Management of Immune-Related Adverse Events from Immune-Checkpoint Inhibitors in Advanced or Metastatic Renal Cell Carcinoma
Katharina Leucht, Nalyan Ali, Susan Foller, et al.
Urologie (Heidelberg, Germany)
|
August 4, 2023
Marc-Oliver Grimm, Susan Foller, Mirjam Leeder, et al.
Journal of Clinical Medicine
|
February 26, 2020
New First Line Treatment Options of Clear Cell Renal Cell Cancer Patients with PD-1 or PD-L1 Immune-Checkpoint Inhibitor-Based Combination Therapies
Marc-Oliver Grimm, Katharina Leucht, Viktor Grünwald, et al.
Urologie (Heidelberg, Germany)
|
June 9, 2023
[Antibody-drug conjugates as new therapeutic agents in uro-oncology]
Marc-Oliver Grimm, Susan Foller, Mirjam Leeder, et al.
Cancers
|
October 26, 2024
Complications of Tumor Nephrectomy with and Without Tumor Thrombus in the Vena Cava, Recorded with the Clavien-Dindo Classification: A Matched-Pair Analysis
Ute Maria Frölich, Katharina Leucht, Marc-Oliver Grimm, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
January 9, 2016
Prostate cancer treated with image-guided helical TomoTherapy® and image-guided LINAC-IMRT : Correlation between high-dose bladder volume, margin reduction, and genitourinary toxicity
Sonia Drozdz, Michael Schwedas, Henning Salz, et al.
Der Urologe. Ausg. A
|
June 8, 2021
[Side effects of immune checkpoint inhibitor treatment of urological tumors]
Marc-Oliver Grimm, Tobias Gottschlich, Nalyan Ali, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Aktuelle Urologie
|
March 28, 2018
[Immunotherapy for renal cell carcinoma - current status]
Marc-Oliver Grimm, Susan Foller
Urologie (Heidelberg, Germany)
|
November 17, 2023
[Combination therapy with poly(adenosine diphosphate-ribose) polymerase (PARPi) and androgen receptor signaling pathway (ARPi) inhibitors for metastatic castration-resistant prostate cancer]
Marc-Oliver Grimm, Susan Foller, Katharina Leucht
Journal of Clinical Medicine
|
November 27, 2021
Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma
Marc-Oliver Grimm, Katharina Leucht, Susan Foller
Cancers
|
September 23, 2022
Management of Immune-Related Adverse Events from Immune-Checkpoint Inhibitors in Advanced or Metastatic Renal Cell Carcinoma
Katharina Leucht, Nalyan Ali, Susan Foller, et al.
Urologie (Heidelberg, Germany)
|
August 4, 2023
Marc-Oliver Grimm, Susan Foller, Mirjam Leeder, et al.
Journal of Clinical Medicine
|
February 26, 2020
New First Line Treatment Options of Clear Cell Renal Cell Cancer Patients with PD-1 or PD-L1 Immune-Checkpoint Inhibitor-Based Combination Therapies
Marc-Oliver Grimm, Katharina Leucht, Viktor Grünwald, et al.
Urologie (Heidelberg, Germany)
|
June 9, 2023
[Antibody-drug conjugates as new therapeutic agents in uro-oncology]
Marc-Oliver Grimm, Susan Foller, Mirjam Leeder, et al.
Cancers
|
October 26, 2024
Complications of Tumor Nephrectomy with and Without Tumor Thrombus in the Vena Cava, Recorded with the Clavien-Dindo Classification: A Matched-Pair Analysis
Ute Maria Frölich, Katharina Leucht, Marc-Oliver Grimm, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
January 9, 2016
Prostate cancer treated with image-guided helical TomoTherapy® and image-guided LINAC-IMRT : Correlation between high-dose bladder volume, margin reduction, and genitourinary toxicity
Sonia Drozdz, Michael Schwedas, Henning Salz, et al.
Der Urologe. Ausg. A
|
June 8, 2021
[Side effects of immune checkpoint inhibitor treatment of urological tumors]
Marc-Oliver Grimm, Tobias Gottschlich, Nalyan Ali, et al.
Page
of 4